Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids - Trial NCT06317610
Access comprehensive clinical trial information for NCT06317610 through Pure Global AI's free database. This phase not specified trial is sponsored by Chongqing University Cancer Hospital and is currently Recruiting. The study focuses on Ovarian Cancer. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
growth prediction of ovarian cancer organoids in the frame of bright field image by leveraging AI
Observational
other
Sponsor & Location
Chongqing University Cancer Hospital
Timeline & Enrollment
N/A
Jan 01, 2022
May 30, 2024
Primary Outcome
AUC of growth prediction performance using deep learning model,Accuracy of growth prediction using deep learning model
Summary
The present study aims to collect early bright field image of patient-derived organoids with
 ovarian cancer. By leveraging artificial intelligence, this study will seek to construct and
 refine algorithms that able to predict growth of ovarian cancer organoids.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06317610
Non-Device Trial